Trevi Therapeutics hits 50% enrollment in IPF cough research By Investing.com
NEW HAVEN, Conn. - Trevi Therapeutics, Inc. (NASDAQ:), a clinical-stage biopharmaceutical firm,…
By
admin
NEW HAVEN, Conn. - Trevi Therapeutics, Inc. (NASDAQ:), a clinical-stage biopharmaceutical firm,…
Sign in to your account